Brii Bio Presents Late-Breaking Data from Its Phase 2 ENRICH and ENHANCE Studies at AASLD 2026, Supporting BRII-179-Based Priming and Enrichment Strategy for HBV Functional Cure
The Quick Take
Data across five Phase 2 studies of BRII-179, including ENSURE, ENRICH and ENHANCE, support its potential role in priming HBV-specific immune responses and improving functional cure rates with siRNA-based therapies ENRICH prospectively reproduced the BRII-179 priming effect previously...
Ground Level News aggregates headlines from public feeds. This page shows a short summary only; the full article and all rights belong to PR Newswire M&A.
Related
Business
Jungbunzlauer nomme Johan Westman à son conseil d'administration
BÂLE, Suisse, 5 novembre 2026 /PRNewswire/ -- Johan Westman, 53 ans, a été nommé au conseil d'administration de Jungbunzlauer avec effet immédiat. « Nous…
Business
Industrial Defender erweitert sein Angebot um Netzwerküberwachung und Risk Signal™, um die Cybersicherheit im Bereich der Betriebstechnik (OT) in Europa, Afrika und dem Nahen Osten zu stärken
INSM korreliert jede Netzwerkanomalie mit detaillierten Informationen zu den Anlagen; Risk Signal™ wandelt die Ergebnisse in verifizierte Abhilfemaßnahmen um…
Business
ABEC lance la plateforme ATB™-2100 pour transformer la fabrication des thérapies de pointe
BETHLEHEM, Pennsylvanie, 6 novembre 2026 /PRNewswire/ -- ABEC, un leader mondial des solutions et services d'ingénierie pour la fabrication biopharmaceutique,…
Business
Sensex rallies as overseas funds pump in Rs 14,975 crore
Foreign institutional investors significantly increased their purchases of Indian stocks, leading to substantial market gains. The BSE Sensex rose by 2,008.61…